ALFA Filings
Every announcement, straight from the exchange
Every Aarti Drugs results update announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Aarti Drugs reports Q2 FY27 revenue of ₹828.8 Crore and PAT of ₹82.8 Crore, up 83% YoY. Results reflect record quarterly EBITDA and margin expansion.
Aarti Drugs reported Q1 FY27 consolidated revenue of ₹703.6 crore and EBITDA of ₹96.9 crore, reflecting 19% and 30% YoY growth respectively.
Aarti Drugs reported FY26 revenue of ₹2,567.7 Crore, reflecting 7% year-on-year growth. Net profit reached ₹194.9 Crore, driven by strong sequential recovery and operational scale-up.